Herpes simplex vaccines

Cancer Res. 1976 Feb;36(2 pt 2):857-8.


Prospects for the development of vaccines against herpes simplex virus types 1 and 2 and other herpesvirus group vaccines are discussed from the scientific, medical, and economic standpoints. Probably, the most practical development will be glycoprotein subunit vaccines, prepared from herpes simples virus types 1 and 2, that will be tested for prophylaxis and therapy of acute viral disease and for cancer that may be caused by these agents.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Epitopes
  • Female
  • Herpes Simplex / prevention & control
  • Simplexvirus / immunology*
  • Viral Vaccines*


  • Epitopes
  • Viral Vaccines